Related Experiment Video
Updated: Oct 16, 2026

Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
Promoter-region hypermethylation and gene silencing in human cancer
1Johns Hopkins Oncology Center, Baltimore, MD 21231, USA.
Abstract:
In summary, it is apparent that alterations in DNA methylation are a fundamental molecular change associated with the neoplastic process and have important biologic implications for tumor initiation and progression. The promoter-region hypermethylation events covered in the present chapter are especially critical and can frequently serve as alternative mechanisms for coding-region mutations for loss of key gene function in neoplastic cells. The mechanisms underlying the precise role of this hypermethylation in gene silencing must be further defined, as must the determinants of the hypermethylation changes themselves. The therapeutic implications of promoter-region hypermethylation must be explored, and a potential use for establishing this change as a sensitive biomarker for use in multiple types of cancer-risk assessment and detection assays has already emerged. The next few years should see exciting advances in our understanding of an epigenetic process which, in conjunction with genetic alterations, appears to drive the process of neoplasia.
Insights
DNA methylation alterations are key to cancer development and progression. Promoter hypermethylation silences genes, offering potential as a cancer biomarker.
Area of Science:
- Epigenetics
- Cancer Biology
- Molecular Oncology
Background:
- DNA methylation alterations are fundamental to neoplasia.
- Promoter-region hypermethylation is critical in tumor initiation and progression.
- Hypermethylation can act as an alternative to mutations for gene silencing.
Purpose of the Study:
- To define the precise role of hypermethylation in gene silencing.
- To identify determinants of DNA hypermethylation changes.
- To explore therapeutic implications and biomarker potential of promoter hypermethylation.
Main Methods:
- Review of existing literature on DNA methylation in cancer.
- Analysis of epigenetic mechanisms in neoplastic cells.
- Investigation of gene silencing pathways affected by hypermethylation.
Main Results:
- Promoter-region hypermethylation is a significant mechanism for gene silencing in cancer.
- Hypermethylation can functionally replace coding-region mutations.
- Potential for promoter hypermethylation as a cancer biomarker is emerging.
Conclusions:
- DNA methylation changes are integral to cancer development.
- Further research is needed to fully elucidate hypermethylation mechanisms and therapeutic uses.
- Epigenetic alterations, alongside genetic changes, drive neoplasia.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
MicroRNAs
MicroRNAs
Induced Pluripotent Stem Cells
Somatic cells are...
Abnormal Proliferation

